Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CommonAngels (now known as Converge Venture Partners) is a prominent Boston-based angel investment group and venture capital firm founded in 1998. The organization specializes in early-stage investments in technology-driven sectors, including software, information technology, and life sciences, with a particular focus on medical devices and biotechnology. CommonAngels transitioned from a traditional angel network to a managed venture fund model, rebranding as CommonAngels Ventures in 2013 and later as Converge Venture Partners in 2015. The firm is recognized for its 'operator-first' approach, leveraging a deep network of experienced entrepreneurs and executives to provide mentorship and strategic guidance to its portfolio companies. Notable investments include early-stage startups in the biotechnology, healthcare IT, and enterprise software sectors across the Northeast United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CommonAngels.